t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Cerebral spinal fluid by Molecular genetics method

Q: Why is t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Cerebral spinal fluid by Molecular genetics method ordered?

Providers order this test when results can help evaluate symptoms, monitor conditions, or guide treatment.

Q: How do I prepare for t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Cerebral spinal fluid by Molecular genetics method?

Preparation depends on the specific test and your provider’s instructions.

LOINC: 60576-6Type: OtherCPT: N/A

Medical Disclaimer: This information is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any health-related decisions.

Frequently Asked Questions

A diagnostic test used to support clinical decision-making.

Sources

[1]LOINC — Logical Observation Identifiers Names and Codes. Regenstrief Institute

t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Cerebral spinal fluid by Molecular genetics method

Frequently Asked Questions

What is t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Cerebral spinal fluid by Molecular genetics method?

Why is t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Cerebral spinal fluid by Molecular genetics method ordered?

How do I prepare for t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript major break points [Presence] in Cerebral spinal fluid by Molecular genetics method?